AngioDynamics (ANGO) vs Stereotaxis (STXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
AngioDynamics (ANGO) has outperformed Stereotaxis (STXS) over the past year, gaining 1.0% versus a loss of 68.9%. Over five years, ANGO leads with a -59.0% price change compared with -81.3% for STXS. AngioDynamics is the larger company by market cap ($472.3 million vs $111.2 million), about 4.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | STXS |
|---|---|---|
| Share price | $11.23 | $1.11 |
| Market cap | $472.27M | $111.22M |
| 1-day change | -20.86% | -1.77% |
| YTD return | -12.54% | -51.74% |
| 1-year return | +0.99% | -68.91% |
| 5-year return | -58.97% | -81.28% |
| EPS (TTM) | $-0.88 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.29 | $3.42 |
| 52-week low | $9.39 | $1.09 |
| Distance from 52-week high | -31.06% | -67.54% |
| Analyst consensus | none | none |
| Avg. price target upside | +78.09% | +170.27% |
| Average volume | 557.83K | 808.41K |
| Shares outstanding | 42.05M | 100.20M |
| Employees | 632 | 131 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AngioDynamics is about 4.2 times larger than Stereotaxis by market value ($472.27M vs $111.22M).
- ANGO has outperformed STXS by 69.9 percentage points over the past year.
About AngioDynamics
ANGO stock →AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
Healthcare · Medical Instruments & Supplies · 632 employees
About Stereotaxis
STXS stock →Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Healthcare · Medical Instruments & Supplies · 131 employees
ANGO vs STXS FAQ
Which is bigger, AngioDynamics or Stereotaxis?
AngioDynamics (ANGO) is larger, with a market capitalization of $472.27M compared with $111.22M for Stereotaxis (STXS).
Which stock has performed better over the past year, ANGO or STXS?
ANGO returned +0.99% over the past 12 months, compared with -68.91% for STXS (price return, excluding dividends). Past performance does not predict future results.
Are AngioDynamics and Stereotaxis in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.